GLP-1-Mimetika — wegweisend zur Behandlung von Diabetes und Adipositas
GLP-1-Mimetika — wegweisend zur Behandlung von Diabetes und Adipositas
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
German
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Most obese patients would benefit from 5–10 % of weight loss but fail when using non-surgical approaches. The recent development of two anti-obesity drugs may change that therapeutic gap. Patients receiving long-acting glucagon-like peptide 1 (GLP1) agonist semaglutide achieve weight loss above 10 %. With tirzepatide, a co-agonist for GLP-1 and the...
Alternative Titles
Full title
GLP-1-Mimetika — wegweisend zur Behandlung von Diabetes und Adipositas
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2800406072
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2800406072
Other Identifiers
ISSN
0947-0867
E-ISSN
1868-6249
DOI
10.1007/s12268-023-1919-6
